Literature DB >> 26678314

DNA damage and the balance between survival and death in cancer biology.

Wynand P Roos1, Adam D Thomas1, Bernd Kaina1.   

Abstract

DNA is vulnerable to damage resulting from endogenous metabolites, environmental and dietary carcinogens, some anti-inflammatory drugs, and genotoxic cancer therapeutics. Cells respond to DNA damage by activating complex signalling networks that decide cell fate, promoting not only DNA repair and survival but also cell death. The decision between cell survival and death following DNA damage rests on factors that are involved in DNA damage recognition, and DNA repair and damage tolerance, as well as on factors involved in the activation of apoptosis, necrosis, autophagy and senescence. The pathways that dictate cell fate are entwined and have key roles in cancer initiation and progression. Furthermore, they determine the outcome of cancer therapy with genotoxic drugs. Understanding the molecular basis of these pathways is important not only for gaining insight into carcinogenesis, but also in promoting successful cancer therapy. In this Review, we describe key decision-making nodes in the complex interplay between cell survival and death following DNA damage.

Entities:  

Mesh:

Year:  2015        PMID: 26678314     DOI: 10.1038/nrc.2015.2

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  198 in total

Review 1.  Competition, collaboration and coordination--determining how cells bypass DNA damage.

Authors:  Julian E Sale
Journal:  J Cell Sci       Date:  2012-04-12       Impact factor: 5.285

2.  Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.

Authors:  W P Roos; L F Z Batista; S C Naumann; W Wick; M Weller; C F M Menck; B Kaina
Journal:  Oncogene       Date:  2006-07-03       Impact factor: 9.867

3.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.

Authors:  M Ljungman; H M O'Hagan; M T Paulsen
Journal:  Oncogene       Date:  2001-09-20       Impact factor: 9.867

5.  ATM engages the TSC2/mTORC1 signaling node to regulate autophagy.

Authors:  Angela Alexander; Jinhee Kim; Cheryl L Walker
Journal:  Autophagy       Date:  2010-07-01       Impact factor: 16.016

6.  DNA-protein crosslink repair: proteases as DNA repair enzymes.

Authors:  Julian Stingele; Bianca Habermann; Stefan Jentsch
Journal:  Trends Biochem Sci       Date:  2014-12-09       Impact factor: 13.807

7.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

Review 8.  Bioenergetic aspects of apoptosis, necrosis and mitoptosis.

Authors:  V P Skulachev
Journal:  Apoptosis       Date:  2006-04       Impact factor: 4.677

Review 9.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Harinder Garewal
Journal:  Mutat Res       Date:  2002-06       Impact factor: 2.433

10.  Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Authors:  Alberto Inga; Francesca Storici; Thomas A Darden; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

View more
  327 in total

Review 1.  DNA Damage and Repair Biomarkers of Immunotherapy Response.

Authors:  Kent W Mouw; Michael S Goldberg; Panagiotis A Konstantinopoulos; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2017-06-19       Impact factor: 39.397

2.  Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.

Authors:  Shidong Lv; Haoran Wen; Xiongwei Shan; Jianhua Li; Yaobin Wu; Xinpei Yu; Wenhua Huang; Qiang Wei
Journal:  Epigenetics       Date:  2019-06-28       Impact factor: 4.528

Review 3.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

4.  Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells.

Authors:  Zhihui Che; Fuchen Liu; Wenli Zhang; Mary McGrath; Daisen Hou; Ping Chen; Chunhua Song; Dongqin Yang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 5.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

6.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

7.  Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.

Authors:  Veronika Butin-Israeli; Triet M Bui; Hannah L Wiesolek; Lorraine Mascarenhas; Joseph J Lee; Lindsey C Mehl; Kaitlyn R Knutson; Stephen A Adam; Robert D Goldman; Arthur Beyder; Lisa Wiesmuller; Stephen B Hanauer; Ronen Sumagin
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

8.  HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.

Authors:  Wenqi Shan; Yuanyuan Jiang; Huimei Yu; Qianhui Huang; Lanxin Liu; Xuhui Guo; Lei Li; Qingsheng Mi; Kezhong Zhang; Zengquan Yang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Manipulating the mitochondria activity in human hepatic cell line Huh7 by low-power laser irradiation.

Authors:  Anna Lynnyk; Mariia Lunova; Milan Jirsa; Daria Egorova; Andrei Kulikov; Šárka Kubinová; Oleg Lunov; Alexandr Dejneka
Journal:  Biomed Opt Express       Date:  2018-02-21       Impact factor: 3.732

10.  ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia.

Authors:  Qingyi Tong; Huijuan You; Xintao Chen; Kongchao Wang; Weiguang Sun; Yufeng Pei; Xiaodan Zhao; Ming Yuan; Hucheng Zhu; Zengwei Luo; Yonghui Zhang
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.